Hayes Brown @HayesBrown
New from me: Eli Lilly placing a cap on the price insured patients pay for insulin isn't some kind of corporate altruism. It's a move from a company that can see which way the wind is blowing and wants to get ahead of the curve https://t.co/E1ZVqWcrLE — PolitiTweet.org